Melanoma March is around the corner
2 February 2015
Our fourth annual Melanoma March is fast approaching and with 23 marches happening all over Australia; it is almost time to march for a cure and help us raise over $1 million for vital melanoma research.
Thanks to everyone who has already registered to march in 2015 and has been fundraising to help us reach our goal. Imagine what $1 million could do for melanoma research.
Melanoma March will officially launch with its first marches happening on the 22nd February and continue throughout the month of March with people getting involved all around the country. If you register before the 20th February, you will go into a draw to win a $500 fuel voucher.
You can also help raise money by buying a raffle ticket for only $10 for your chance to win a Toyota Yaris.
Sunday, 22 February 2015 - Melbourne
Sunday, 22 February 2015 -Wollongong
Saturday, 28 February 2015 - Bribie Island
Sunday, 8 March 2015 - Bunbury
Sunday, 15 March 2015 - Canberra
Saturday, 21 March 2015 -Gosford
Saturday, 21 March 2015 - Taree
Sunday, 22 March 2015 - Adelaide
Sunday, 22 March 2015 - Bathurst
Sunday, 22 March 2015 - Bonny Hills
Sunday, 22 March 2015 - Brisbane
Sunday, 22 March 2015 - Cairns
Sunday, 22 March 2015 - Coolangatta
Sunday, 22 March 2015 - Darwin
Sunday, 22 March 2015 - Perth
Sunday, 22 March 2015 - Manly
Sunday, 22 March 2015 - Rockingham
Sunday, 22 March 2015 - Townsville
Sunday, 22 March 2015 - Wagga Wagga
Sunday, 22 March 2015 - Perth
Sunday, 29 March 2015 - Busselton
Sunday, 29 March 2015 - Karratha
Sunday, 29 March 2015 - Picton
Former Executive Director of Melanoma Institute Australia Professor John Thompson awarded the prestigious 2018 RPA Foundation Research Medal.
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.
The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.
Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.
Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.